Saccharomyces boulardii enhances anti-inflammatory effectors and AhR activation via metabolic interactions in probiotic communities

ISME J. 2024 Jan 8;18(1):wrae212. doi: 10.1093/ismejo/wrae212.

Abstract

Metabolic exchanges between strains in gut microbial communities shape their composition and interactions with the host. This study investigates the metabolic synergy between potential probiotic bacteria and Saccharomyces boulardii, aiming to enhance anti-inflammatory effects within a multi-species probiotic community. By screening a collection of 85 potential probiotic bacterial strains, we identified two strains that demonstrated a synergistic relationship with S. boulardii in pairwise co-cultivation. Furthermore, we computationally predicted cooperative communities with symbiotic relationships between S. boulardii and these bacteria. Experimental validation of 28 communities highlighted the role of S. boulardii as a key player in microbial communities, significantly boosting the community's cell number and production of anti-inflammatory effectors, thereby affirming its essential role in improving symbiotic dynamics. Based on our observation, one defined community significantly activated the aryl hydrocarbon receptor-a key regulator of immune response-280-fold more effectively than the community without S. boulardii. This study underscores the potential of microbial communities for the design of more effective probiotic formulations.

Keywords: S. boulardii; Genome-scale metabolic modelling; anti-inflammatory; co-culture; inflammation; metabolic interaction; microbial communities; probiotics.

MeSH terms

  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Bacteria / classification
  • Bacteria / genetics
  • Bacteria / metabolism
  • Gastrointestinal Microbiome*
  • Humans
  • Microbial Interactions
  • Probiotics*
  • Receptors, Aryl Hydrocarbon* / metabolism
  • Saccharomyces boulardii* / metabolism
  • Symbiosis

Substances

  • Receptors, Aryl Hydrocarbon
  • Anti-Inflammatory Agents